Golden Dragon (CPMD) Stock Price, News & Analysis

Company Overview

CannaPharmaRX, Inc. operates in the cannabis industry in Canada. It evaluates, negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.

Key Stats

• Today's Range: $0.0015 to $0.0032
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0110
• Volume: 33,720 shs
• Average Volume: 142,628 shs
• Market Capitalization: $1.65 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CPMD Stock Analysis - Frequently Asked Questions

How have CPMD shares performed this year?

Golden Dragon's stock was trading at $0.0081 at the beginning of the year. Since then, CPMD shares have decreased by 69.1% and is now trading at $0.0025.

How were Golden Dragon's earnings last quarter?

Golden Dragon Holding Co. (OTCMKTS:CPMD) announced its earnings results on Thursday, April, 10th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.48 million for the quarter.

How do I buy shares of Golden Dragon?

Shares of CPMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Golden Dragon own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Golden Dragon investors own include FuelCell Energy (FCEL), Blackstone (BX), Global Helium (HECOF), Trillium Therapeutics (TRIL), AFC Gamma (AFCG) and American Lithium (AMLI).

Company Calendar

• Last Earnings: 4/10/2025
• Today: 8/19/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:CPMD
• CIK: 1081938
• Web: www.cannapharmarx.com
• Phone: (949) 652-6838
• Fax: 720-875-1905
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$9.91 million
• Net Margins: -423.36%
• Pretax Margin: 99.11%
• Return on Equity: N/A
• Return on Assets: -34.34%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.05
• Quick Ratio: 0.01

Sales & Book Value

• Annual Sales: $820 thousand
• Price / Sales: 2.58
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.03) per share
• Price / Book: -0.11

Miscellaneous

• Outstanding Shares: 660,626,000
• Free Float: 652,236,000
• Market Cap: $2.11 million
• Optionable: Not Optionable
• Beta: 2.12